These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 26665192)
1. [Role of tumour cell invasion/migration in the vascularisation of experimental lung metastases]. Szabó V; Bugyik E; Dezsõ K; Tóvári J; Döme B; Paku S Magy Onkol; 2015 Dec; 59(4):319-23. PubMed ID: 26665192 [TBL] [Abstract][Full Text] [Related]
2. [Mechanism of tumour vascularisation in experimental lung metastases]. Szabó V Magy Onkol; 2020 Mar; 64(1):73-75. PubMed ID: 32181766 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of tumour vascularization in experimental lung metastases. Szabo V; Bugyik E; Dezso K; Ecker N; Nagy P; Timar J; Tovari J; Laszlo V; Bridgeman VL; Wan E; Frentzas S; Vermeulen PB; Reynolds AR; Dome B; Paku S J Pathol; 2015 Feb; 235(3):384-96. PubMed ID: 25319725 [TBL] [Abstract][Full Text] [Related]
4. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models. Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259 [TBL] [Abstract][Full Text] [Related]
5. Modelling the role of angiogenesis and vasculogenesis in solid tumour growth. Stamper IJ; Byrne HM; Owen MR; Maini PK Bull Math Biol; 2007 Nov; 69(8):2737-72. PubMed ID: 17874270 [TBL] [Abstract][Full Text] [Related]
6. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo. Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178 [TBL] [Abstract][Full Text] [Related]
7. Quantitative comparison of the morphology of the microvasculature of primary lung lesions and metastatic brain tumours. McCurley CR; Shivers RR; Del Maestro RF J Submicrosc Cytol Pathol; 1998 Apr; 30(2):257-69. PubMed ID: 9648289 [TBL] [Abstract][Full Text] [Related]
8. The vascular network of tumours--what is it not for? Sivridis E; Giatromanolaki A; Koukourakis MI J Pathol; 2003 Oct; 201(2):173-80. PubMed ID: 14517833 [TBL] [Abstract][Full Text] [Related]
9. RNAi-mediated MMP-9 silencing inhibits mouse melanoma cell invasion and migration in vitro and in vivo. Tang ZY; Liu Y; Liu LX; Ding XY; Zhang H; Fang LQ Cell Biol Int; 2013 Aug; 37(8):849-54. PubMed ID: 23554050 [TBL] [Abstract][Full Text] [Related]
10. Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases. Raynor A; Jantscheff P; Ross T; Schlesinger M; Wilde M; Haasis S; Dreckmann T; Bendas G; Massing U Lipids Health Dis; 2015 Jul; 14():69. PubMed ID: 26162894 [TBL] [Abstract][Full Text] [Related]
11. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Denekamp J Br J Radiol; 1993 Mar; 66(783):181-96. PubMed ID: 7682469 [TBL] [Abstract][Full Text] [Related]
14. Morphological aspects of angiogenesis in experimental liver metastases. Paku S; Lapis K Am J Pathol; 1993 Sep; 143(3):926-36. PubMed ID: 7689793 [TBL] [Abstract][Full Text] [Related]
15. Lung cancer neovascularisation: Cellular and molecular interaction between endothelial and lung cancer cells. Kaessmeyer S; Bhoola K; Baltic S; Thompson P; Plendl J Immunobiology; 2014 Apr; 219(4):308-14. PubMed ID: 24355365 [TBL] [Abstract][Full Text] [Related]
16. The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway. Sugino T; Yamaguchi T; Ogura G; Kusakabe T; Goodison S; Homma Y; Suzuki T J Pathol; 2007 Jun; 212(2):152-60. PubMed ID: 17455170 [TBL] [Abstract][Full Text] [Related]
17. 3D power Doppler analysis of the vascularisation in tumours of the oral cavity. Rebol J; Brkljacić B; Bumber Z; Psenicnik S; Povalej P Ultraschall Med; 2007 Feb; 28(1):40-4. PubMed ID: 16703486 [TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches? Coelho AL; Gomes MP; Catarino RJ; Rolfo C; Lopes AM; Medeiros RM; Araújo AM Oncotarget; 2017 Jun; 8(24):39795-39804. PubMed ID: 26950275 [TBL] [Abstract][Full Text] [Related]
19. The endothelial marker CD 34 in the assessment of tumour vascularisation in ovarian cancer. Heimburg S; Oehler MK; Kristen P; Papadopoulos T; Caffier H Anticancer Res; 1997; 17(4B):3149-51. PubMed ID: 9329623 [TBL] [Abstract][Full Text] [Related]
20. Visualization of immediate immune responses to pioneer metastatic cells in the lung. Headley MB; Bins A; Nip A; Roberts EW; Looney MR; Gerard A; Krummel MF Nature; 2016 Mar; 531(7595):513-7. PubMed ID: 26982733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]